Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,573 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Plants as biofactories.
Mett V, Farrance CE, Green BJ, Yusibov V. Mett V, et al. Biologicals. 2008 Nov;36(6):354-8. doi: 10.1016/j.biologicals.2008.09.001. Epub 2008 Oct 19. Biologicals. 2008. PMID: 18938088 Review.
Immunogenicity of hemagglutinin from A/Bar-headed Goose/Qinghai/1A/05 and A/Anhui/1/05 strains of H5N1 influenza viruses produced in Nicotiana benthamiana plants.
Shoji Y, Farrance CE, Bi H, Shamloul M, Green B, Manceva S, Rhee A, Ugulava N, Roy G, Musiychuk K, Chichester JA, Mett V, Yusibov V. Shoji Y, et al. Among authors: green b. Vaccine. 2009 May 26;27(25-26):3467-70. doi: 10.1016/j.vaccine.2009.01.051. Epub 2009 Feb 5. Vaccine. 2009. PMID: 19200814
A plant-based system for rapid production of influenza vaccine antigens.
Shoji Y, Farrance CE, Bautista J, Bi H, Musiychuk K, Horsey A, Park H, Jaje J, Green BJ, Shamloul M, Sharma S, Chichester JA, Mett V, Yusibov V. Shoji Y, et al. Influenza Other Respir Viruses. 2012 May;6(3):204-10. doi: 10.1111/j.1750-2659.2011.00295.x. Epub 2011 Oct 4. Influenza Other Respir Viruses. 2012. PMID: 21974811 Free PMC article.
Safety and immunogenicity of a plant-produced recombinant hemagglutinin-based influenza vaccine (HAI-05) derived from A/Indonesia/05/2005 (H5N1) influenza virus: a phase 1 randomized, double-blind, placebo-controlled, dose-escalation study in healthy adults.
Chichester JA, Jones RM, Green BJ, Stow M, Miao F, Moonsammy G, Streatfield SJ, Yusibov V. Chichester JA, et al. Viruses. 2012 Nov 19;4(11):3227-44. doi: 10.3390/v4113227. Viruses. 2012. PMID: 23202523 Free PMC article. Clinical Trial.
Safety and immunogenicity of a plant-produced recombinant monomer hemagglutinin-based influenza vaccine derived from influenza A (H1N1)pdm09 virus: a Phase 1 dose-escalation study in healthy adults.
Cummings JF, Guerrero ML, Moon JE, Waterman P, Nielsen RK, Jefferson S, Gross FL, Hancock K, Katz JM, Yusibov V; Fraunhofer USA Center for Molecular Biotechnology Study Group. Cummings JF, et al. Vaccine. 2014 Apr 17;32(19):2251-9. doi: 10.1016/j.vaccine.2013.10.017. Epub 2013 Oct 12. Vaccine. 2014. PMID: 24126211 Free PMC article. Clinical Trial.
Immunogenicity of H1N1 influenza virus-like particles produced in Nicotiana benthamiana.
Shoji Y, Prokhnevsky A, Leffet B, Vetter N, Tottey S, Satinover S, Musiychuk K, Shamloul M, Norikane J, Jones RM, Chichester JA, Green BJ, Streatfield SJ, Yusibov V. Shoji Y, et al. Among authors: green bj. Hum Vaccin Immunother. 2015;11(1):118-23. doi: 10.4161/hv.34365. Epub 2014 Nov 1. Hum Vaccin Immunother. 2015. PMID: 25483524 Free PMC article.
2,573 results